Oregon Health & Science University (OHSU) spinoff DeltaPoint, Inc., was selected as the overall launch-stage winner in the annual Angel Oregon event hosted by the Oregon Entrepreneurs Network. The company took home a $170,000 angel investment prize. DeltaPoint is commercializing diagnostic software developed at OHSU’s Advanced Imaging Research Center that is designed to noninvasively detect, diagnose, and monitor breast cancer using a novel algorithm to analyze the results of magnetic resonance imaging (MRI). The technology is the first MRI software that can reliably differentiate benign from malignant tumors, according to DeltaPoint, which plans to expand the platform to address other forms of cancer. The technology licensed to DeltaPoint was supported by a grant from OHSU’s Bioscience Innovation Program (BSIP), which “is one of a growing number of gap funding programs created by universities across the country to speed the commercialization of university inventions,” explains Kristin Rencher, director of technology development in OHSU’s Office of Technology Transfer and Business Development.